Sclerotherapy of lymphangiomas of the head and neck

Head Neck. 2011 Nov;33(11):1649-55. doi: 10.1002/hed.21552. Epub 2010 Aug 24.

Abstract

Lymphangiomas are congenital malformations of the lymphatic system that consist of cysts of varying size. Although they are benign, they can undergo progressive growth with compression and infiltration of adjacent structures. Surgical excision has been the cornerstone of treatment, although total excision of the lymphangioma can be a major challenge and may be associated with severe complications. Therefore, a variety of nonsurgical methods have been proposed to reduce the surgical morbidity and to decrease the recurrence rate. Percutaneous sclerotherapy of lymphangioma involves the injection of sclerosing substances into the lymphangioma cysts. During the past years, different sclerosants and sclerosant techniques have been developed. This review summarizes the current knowledge on sclerotherapy of lymphangiomas of the head and neck.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Bleomycin / therapeutic use
  • Diatrizoate / therapeutic use
  • Doxycycline / therapeutic use
  • Drug Combinations
  • Ethanol / therapeutic use
  • Fatty Acids / therapeutic use
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms / diagnosis
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Lymphangioma / diagnosis
  • Lymphangioma / therapy*
  • Male
  • Picibanil / therapeutic use
  • Propylene Glycols / therapeutic use
  • Risk Assessment
  • Sclerosing Solutions / therapeutic use*
  • Sclerotherapy / methods*
  • Treatment Outcome
  • Zein / therapeutic use

Substances

  • Drug Combinations
  • Fatty Acids
  • Propylene Glycols
  • Sclerosing Solutions
  • Bleomycin
  • Diatrizoate
  • Picibanil
  • Ethanol
  • Zein
  • alcoholic prolamine solution
  • Doxycycline